Navigation Links
Iron supplementation quite necessary

Hypertensive drugs in general have a common side effect- cough. Iron supplementation cures the annoying cough that often plagues people on a widely-used blood pressure medication.
The angiotensin-converting enzyme (ACE) inhibitors are often used to treat high blood pressure, heart failure and other cardiac conditions. //But up to 40% of people on ACE inhibitors are troubled by a cough. The side effect is not considered serious by doctors, but it is the most common reason why patients abandon ACE inhibitors.//

In Seoul, at the School of Medicine, researchers, have found a way of treating the cough. They gave ten patients on ACE inhibitors, with the cough, iron supplements of 256 milligrams a day. Another nine patients were given a placebo. After four weeks, eight of those on iron found their cough significantly improved, and for three it had virtually disappeared. There was no such improvement in the placebo group.

The researchers say that iron decreases levels of nitric oxide, a hormone that is known to irritate the lungs. It is very difficult to state that iron should be recommended to patients on ACE inhibitors who are troubled by a cough. Since this is a small study, it is too soon to come to conclusions. Extensive work should prove effective.


'"/>




Page: 1

Related medicine news :

1. Iron supplementation for a common side effect
2. Hyaluronan supplementation therapy for Knee Osteoarthritis
3. Lower chance of bone fracture with Vitamin D supplementation
4. Dietary supplementation of Folic Acid Requires Critical Evaluation
5. Fish Oil supplementation reduces physical aggression in school children’
6. Vitamin A supplementation inadequate in India: Need for effective strategies
7. More Accurate "PROSTATE CANCER" Test can save Unnecessary Biopsies
8. Exercise is necessary in daily life
9. Unnecessary Pap Smears
10. New Implantable Cardioverter Defibrillators to avoid unnecessary shocks
11. Unnecessary Catheterization Puts Elderly Patients at Risk
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/23/2017)... ... , ... Silicon Valley Hair Institute, the leading hair transplant center in the ... the ARTAS® hair transplant system and the younger demographic. As many younger people suffer ... methods of hair restoration. , “It can be emotionally difficult for young men and ...
(Date:9/22/2017)... ... September 22, 2017 , ... PITTSBURGH...Defibrillators are used to treat ... if one isn’t accessible in certain locations, the risk of death can be ... with this idea," said an inventor from Ridgecrest, Calif. , The MOBILE AUTOMATED ...
(Date:9/22/2017)... , ... September 22, 2017 , ... ... firm in Pennsylvania, is pleased to offer in-home and online newborn sleep ... sleep deprivation has on the body,” says company owner Courtney Zentz, a pediatric ...
(Date:9/22/2017)... ... , ... “Cursed with a Curse: The Truth about Tithing”: ... experienced when breaking free from this misconception. “Cursed with a Curse: The Truth ... by Christian Faith Publishing, Lysa M. Harrison’s new book is a powerful and ...
(Date:9/22/2017)... Francisco, CA (PRWEB) , ... September 22, 2017 ... ... way to help you brush more effectively even on the go. Their electric ... like gingivitis and gum inflammation, with UV sanitizing technology. Combining leading edge Enke ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... , Sept. 7, 2017 NuvoAir (formerly ... Spirometer, announced today a partnership with Novartis Pharma AG to ... NuvoAir,s position as the leading mobile spirometry platform and Novartis, ... ... ...
(Date:9/6/2017)... -- Robert G. Szewc, M.D., is recognized by Continental Who,s ... his contributions to the Medical field.      ... practice of Kidney and Hypertension Specialists, which specializes in ... He has worked in this position since 2002, and ... as expertise in kidneys, hypertension, chronic disease and anemia, ...
(Date:9/6/2017)... 2017 NeuroRx, a clinical stage biopharma company developing ... (ASIB), has been granted Fast Track status by the US ... (ketamine HCl) followed by NRX-101 (D-cycloserine + lurasidone). The company ... this sequential therapy targeting patients who are admitted to Emergency ... ...
Breaking Medicine Technology: